Navigation Links
AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
Date:9/28/2007

AppyScore(TM), the First Blood-based Screen / Triage Test for Human Appendicitis, Advances in FDA Application Process with Test Results Showing

Sensitivity Level of 98%.

CASTLE ROCK, Colo., Sept. 28 /PRNewswire-FirstCall/ -- AspenBio Pharma, Inc. (Nasdaq: APPY) an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, today announced strong results from the latest pre-FDA multi-hospital study using its AppyScore(TM) human appendicitis screen / triage blood test. AspenBio has also commenced the formal regulatory approval process for the AppyScore test by applying for a pre-investigational device exemption ("IDE") from the United States Food and Drug Administration ("FDA").

This large pre-FDA study was designed to provide a statistically significant confirmation of the performance, including utility and accuracy, of the AppyScore appendicitis screen / triage test in an emergency room setting. A secondary purpose of the study was to optimize sampling and testing methodologies in preparation for clinical studies to be conducted with the final In Vitro Diagnostic ("IVD") device that will be submitted for FDA review. The study was conducted at multiple hospital sites under appropriate Institutional Review Board Approvals, which included patient consent.

AspenBio's president and CEO, Richard Donnelly, commented, "These latest test results have significantly advanced our understanding of the test as well as our confidence in its performance and value to medicine. By doing so, we achieved the key objective of our study. With sufficient statistical power based on ample numbers of pathology-confirmed appendicitis patien
'/>"/>

SOURCE AspenBio Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... (NYSE: CVS ) officially announced today that it will rebuild ... fire damage during protests last week.  "As we watched ... past week or so, our hearts turned from pain to the ... Larry Merlo . "Our purpose as a company is helping ... way that we can fulfill that purpose than to reopen our ...
(Date:5/6/2015)... 6, 2015 Fibich, Leebron, Copeland, Briggs & ... settlement has been reached to resolve lawsuits involving individuals ... Actos. Actos - manufactured by Takeda Pharmaceuticals - has ... cancer. Several of the firm,s attorneys were instrumental in ... Tommy Fibich - Founding Partner of Fibich, ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. The ...
Breaking Medicine Technology:CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... 15, 2011 Nephros, Inc. (OTC Bulletin Board: ... marketing filtration products for therapeutic applications, infection control, and ... Inc. effected a one-for-twenty reverse stock split at 5:00 ... by the Financial Industry Regulatory Authority (FINRA) that FINRA ...
... and BALTIMORE, March 15, 2011 ... innovate, implement and commercialize next generation of medical image ... leading clinicians and advanced engineering technologists. ... international communications and information technology company, and Johns Hopkins ...
Cached Medicine Technology:Nephros Announces Split Adjusted Trade Date 2Nephros Announces Split Adjusted Trade Date 3Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2
(Date:5/6/2015)... Falls Church, VA (PRWEB) May 07, 2015 ... the Impact of NSF/IPEC/ANSI 363-2014, **FDAnews Webinar**, May ... EDT, http://www.fdanews.com/NewGMPStandards , Most drugs contain ... flow aids, binding agents or other purposes that ... The globalization of the pharma industry, combined with ...
(Date:5/6/2015)... With recent headlines about the kidnapping of Bossini clothing ... from Southern China, it is becoming apparent to people all ... them. This is especially true for High Net Worth Individuals ... through the property they own, the schools their children attend ... individuals, families and companies that are at higher risk than ...
(Date:5/6/2015)... Jersey (PRWEB) May 06, 2015 With ... asthma and subject to its potentially dangerous health effects, ... state-wide program – BEAM (Breathe Easier with Asthma Management) ... The program is being funded through a $500,000 foundation ... Jersey (BGCNJ), which is implementing BEAM throughout the state. ...
(Date:5/6/2015)... As the exclusive hospital of the Tampa Bay Buccaneers, Florida ... Raymond James Stadium for all the “Bucs Babies” celebrating their ... into the “Bucs Babies” program last year. , “It ... particularly those born at the Florida Hospitals here in our ... really enjoyed my time participating in the festivities, interacting with ...
(Date:5/6/2015)... Beach, VA (PRWEB) May 06, 2015 ... and services, today announced it won the Software ... CODiE Award in the "Best Postsecondary Learning Management ... in 2011 and has been finalists for this award ... and innovation that stands out in the industry. ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 3Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 4Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3
... Neurobiological,Technologies, Inc. ("NTI") (Nasdaq: NTII ) today ... by The NASDAQ Stock Market that it has,regained ... Previously, the NASDAQ Listing Qualifications Department had,notified NTI ... $35 million market,value of listed securities continued listing ...
... for Baby Boomers In ... Search of Better Sex, ... during the,holidays that recipients will love. But one product is, in ... ), To view the Multimedia News Release, go to: ...
... November 20 Stora Enso, a leading producer,of ... the first,intelligent pharmaceutical packaging solution to use Cypak,s ... electronic module built,around a single RFID microchip and ... sensors are printed onto the packaging,to detect when ...
... WHO Cuts Global AIDS Estimate by Six Million; AHF Questions Numbers, Seeks ... ... As the World Health,Organization (WHO) prepares to announce a dramatic decrease in ... to 33,million in a report to be released Wednesday, AIDS Healthcare Foundation,(AHF) ...
... MYL ),announced that it completed the sale of 2.14 ... per share and 53.5 million,shares of common stock at ... filed with the Securities and Exchange Commission. The,amounts sold ... underwriters, exercise of the overallotment option. The offerings ...
... Viant, Inc., a leader in,healthcare payment and cost ... as Executive Vice President of Network,Development. Mr. Vangeison ... on delivering quality and value to many of ... Vangeison will have responsibility for all network strategy,including ...
Cached Medicine News:Health News:Give the Gift of Love With Women's Intimacy Product that Increases Pleasure for Both Partners 2Health News:Give the Gift of Love With Women's Intimacy Product that Increases Pleasure for Both Partners 3Health News:Cypak Compliancy Connection Powers Stora Enso Pharma DDSi 2Health News:WHO's New Global AIDS Numbers: 'Let's Stop Guessing,' Says AHF 2Health News:Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock 2Health News:Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock 3Health News:Viant Appoints Keith Vangeison as Executive Vice President of Network Development 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: